Prolonged SARS-CoV-2 infection during autologous hematopoietic stem cell transplantation from Hodgkin's lymphoma: a case report.
Pan Afr Med J
; 44: 133, 2023.
Article
in English
| MEDLINE | ID: covidwho-2290450
ABSTRACT
Autologous hematopoietic stem cell transplantation (HSCT) for relapsed Hodgkin's lymphoma increases the risk of infection by using intensive chemotherapy. This risk is obviously ongoing given the increased virulence of severe COVID-19. We report a case of a young man with Hodgkin's lymphoma who received conditioning chemotherapy followed by autologous HSCT and tested positive for SARS-CoV-2 by polymerase chain reaction (PCR) during the early phase of aplasia with persistence of COVID-19 beyond 30 days with favorable follow-up and clinical improvement on treatment. For this type of patient with hematologic malignancy, viral infection can be fatal and strict medical precautions with isolation rules must be maintained, especially for SARS-CoV-2.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Hodgkin Disease
/
Hematopoietic Stem Cell Transplantation
/
COVID-19
Type of study:
Case report
/
Cohort study
/
Prognostic study
Limits:
Humans
/
Male
Language:
English
Journal:
Pan Afr Med J
Year:
2023
Document Type:
Article
Affiliation country:
Pamj.2023.44.133.36277
Similar
MEDLINE
...
LILACS
LIS